BelHealth Says Geritrex Hid FDA Probe Before $14M Stake Deal
A unit of private equity firm BelHealth sued privately held pharmaceutical company Geritrex on Friday in New York state court, saying the drugmaker withheld information about a U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article